Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Aderis Pharmaceuticals Inc Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. |
United States | 9 Oct 2001 | Series D Initial investment. Round participant. Active |
|
|
SV Fund VI |
19 Oct 2016 | Fund Closing USD 30,000,000 (USD 30,000,000) deal size. Initial investment. Round participant. 7.5% of total commitments., Active |